LON:OXP

Oxford Pharmascience Group Share Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume16,260 shs
Average Volume803,502 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Receive OXP News and Ratings via Email

Sign-up to receive the latest news and ratings for Oxford Pharmascience Group and its competitors with MarketBeat's FREE daily newsletter.


Oxford Pharmascience Group logo

About Oxford Pharmascience Group

Oxford Pharmascience Group plc is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in re-developing medicines. The Company primarily engages in research and development activities based around its core technology platforms and focuses on commercializing the related products to pharmaceutical organizations. It operates through one segment, being the development and commercialization of drug products from proprietary technology platforms. The Company operates in three main geographic areas, such as the United Kingdom, Middle East and Brazil. The Company is primarily focused on commercialization efforts for its compounds OXPzero Ibuprofen and OXPzero Naproxen and in regulatory, technical and clinical activities in support of these assets. It is focused on establishing a number of commercial partnerships that demonstrate the commercial feasibility of the technology. The Company's subsidiaries include Oxford Pharmascience Limited and Oxford Nutra Limited.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

0.67 out of 5 stars

Analyst Opinion: 0.0Community Rank: 3.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Oxford Pharmascience Group (LON:OXP) Frequently Asked Questions

What stocks does MarketBeat like better than Oxford Pharmascience Group?

Wall Street analysts have given Oxford Pharmascience Group a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Oxford Pharmascience Group wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are Oxford Pharmascience Group's key executives?

Oxford Pharmascience Group's management team includes the following people:
  • Marcelo Leonardo Bravo, Chief Executive Officer, Executive Director
  • Christopher Hill, Chief Financial Officer, Executive Director, Company Secretary
  • David Robert Norwood, Non-Executive Chairman of the Board (Age 48)
  • James Nicholas Gerald White, Non-Executive Deputy Chairman of the Board
  • John Geoffery Goddard, Independent Non-Executive Director
  • Karl Robertson Van Horn, Independent Non-Executive Director (Age 80)

Who are some of Oxford Pharmascience Group's key competitors?

What other stocks do shareholders of Oxford Pharmascience Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Oxford Pharmascience Group investors own include Oxford Biomedica (OXB), International Biotechnology Trust (IBT), Aphria (APHA), (APHA), Man Group (EMG), Richland Resources Ltd (RLD.L) (RLD), The Restaurant Group (RTN), 32Red (TTR), Haydale Graphene Industries (HAYD) and 326553 (GWP.L) (GWP).

What is Oxford Pharmascience Group's stock symbol?

Oxford Pharmascience Group trades on the London Stock Exchange (LON) under the ticker symbol "OXP."

How do I buy shares of Oxford Pharmascience Group?

Shares of OXP and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

How many employees does Oxford Pharmascience Group have?

Oxford Pharmascience Group employs 147,000 workers across the globe.

What is Oxford Pharmascience Group's official website?

The official website for Oxford Pharmascience Group is www.oxfordpharmascience.com.

Where are Oxford Pharmascience Group's headquarters?

Oxford Pharmascience Group is headquartered at 2 Royal College Street, LONDON, NW1 0NH, United Kingdom.

How can I contact Oxford Pharmascience Group?

Oxford Pharmascience Group's mailing address is 2 Royal College Street, LONDON, NW1 0NH, United Kingdom. The company can be reached via phone at +44-20-75545875.


This page was last updated on 9/19/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.